• 1894 Citations
  • 22 h-Index
1980 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Rasim A. Gucalp is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
pamidronate Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Hypercalcemia Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Fever Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Interleukin-2 Medicine & Life Sciences
Autologous Transplantation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications 1980 2019

  • 1894 Citations
  • 22 h-Index
  • 55 Article
  • 1 Review article

Immune Checkpoint Blockade Is Associated With Durable Responses in Pulmonary Sarcomatoid Carcinoma

Sukrithan, V., Sandler, J., Gucalp, R. A., Gralla, R. J. & Halmos, B., Jan 1 2019, (Accepted/In press) In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

Tumor Burden
Immunotherapy
Carcinoma
Lung
pembrolizumab
Vulnerable Populations
Primary Care Physicians
Lung Neoplasms
Primary Health Care
Mortality
2 Citations (Scopus)

Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: Updated analysis of the observational GioTag study

Hochmair, M. J., Morabito, A., Hao, D., Yang, C. T., Soo, R. A., Yang, J. C. H., Gucalp, R. A., Halmos, B., Wang, L., Märten, A. & Cufer, T., Jan 1 2019, In : Future Oncology. 15, 25, p. 2905-2914 10 p.

Research output: Contribution to journalReview article

Open Access
Non-Small Cell Lung Carcinoma
Observational Studies
Treatment Failure
Mutation
Survival
1 Citation (Scopus)
Lung Neoplasms
Early Detection of Cancer
Mortality
Advisory Committees
Primary Health Care
24 Citations (Scopus)

Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: An observational study

Hochmair, M. J., Morabito, A., Hao, D., Yang, C. T., Soo, R. A., Yang, J. C. H., Gucalp, R. A., Halmos, B., Wang, L., Golembesky, A., Märten, A. & Cufer, T., Nov 1 2018, In : Future Oncology. 14, 27, p. 2861-2874 14 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Observational Studies
Mutation
Therapeutics
Multicenter Studies